1. Home
  2. BA vs NVO Comparison

BA vs NVO Comparison

Compare BA & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boeing Company (The)

BA

Boeing Company (The)

N/A

Current Price

$210.30

Market Cap

182.2B

Sector

Industrials

ML Signal

N/A

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

N/A

Current Price

$43.14

Market Cap

199.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BA
NVO
Founded
1916
1923
Country
United States
Denmark
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
182.2B
199.4B
IPO Year
2006
2001

Fundamental Metrics

Financial Performance
Metric
BA
NVO
Price
$210.30
$43.14
Analyst Decision
Strong Buy
Hold
Analyst Count
16
11
Target Price
$269.75
$51.00
AVG Volume (30 Days)
4.7M
9.4M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
N/A
3.19%
EPS Growth
113.51
N/A
EPS
N/A
N/A
Revenue
$89,463,000,000.00
N/A
Revenue This Year
$12.16
N/A
Revenue Next Year
$14.78
$3.70
P/E Ratio
N/A
$13.60
Revenue Growth
34.50
N/A
52 Week Low
$176.77
$35.12
52 Week High
$254.35
$64.16

Technical Indicators

Market Signals
Indicator
BA
NVO
Relative Strength Index (RSI) 35.97 39.58
Support Level $198.05 $43.29
Resistance Level $231.87 $51.38
Average True Range (ATR) 3.75 0.90
MACD -0.60 -0.16
Stochastic Oscillator 1.61 0.00

Price Performance

Historical Comparison
BA
NVO

About BA Boeing Company (The)

Boeing is a major aerospace and defense firm operating in three segments: commercial airplanes; defense, space, and security; and global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed Martin and Northrop Grumman to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: